Cargando…
Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases
[Image: see text] Allylic cyclitols were investigated as covalent inhibitors of glycoside hydrolases by chemical, enzymatic, proteomic, and computational methods. This approach was inspired by the C(7) cyclitol natural product streptol glucoside, which features a potential carbohydrate leaving group...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131216/ https://www.ncbi.nlm.nih.gov/pubmed/37124289 http://dx.doi.org/10.1021/jacsau.3c00037 |
_version_ | 1785031128979079168 |
---|---|
author | Grayfer, Tatyana D. Yamani, Khalil Jung, Erik Chesnokov, Gleb A. Ferrara, Isabella Hsiao, Chien-Chi Georgiou, Antri Michel, Jeremy Bailly, Aurélien Sieber, Simon Eberl, Leo Gademann, Karl |
author_facet | Grayfer, Tatyana D. Yamani, Khalil Jung, Erik Chesnokov, Gleb A. Ferrara, Isabella Hsiao, Chien-Chi Georgiou, Antri Michel, Jeremy Bailly, Aurélien Sieber, Simon Eberl, Leo Gademann, Karl |
author_sort | Grayfer, Tatyana D. |
collection | PubMed |
description | [Image: see text] Allylic cyclitols were investigated as covalent inhibitors of glycoside hydrolases by chemical, enzymatic, proteomic, and computational methods. This approach was inspired by the C(7) cyclitol natural product streptol glucoside, which features a potential carbohydrate leaving group in the 4-position (carbohydrate numbering). To test this hypothesis, carbocyclic inhibitors with leaving groups in the 4- and 6- positions were prepared. The results of enzyme kinetics analyses demonstrated that dinitrophenyl ethers covalently inhibit α-glucosidases of the GH13 family without reactivation. The labeled enzyme was studied by proteomics, and the active site residue Asp214 was identified as modified. Additionally, computational studies, including enzyme homology modeling and density functional theory (DFT) calculations, further delineate the electronic and structural requirements for activity. This study demonstrates that previously unexplored 4- and 6-positions can be exploited for successful inhibitor design. |
format | Online Article Text |
id | pubmed-10131216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-101312162023-04-27 Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases Grayfer, Tatyana D. Yamani, Khalil Jung, Erik Chesnokov, Gleb A. Ferrara, Isabella Hsiao, Chien-Chi Georgiou, Antri Michel, Jeremy Bailly, Aurélien Sieber, Simon Eberl, Leo Gademann, Karl JACS Au [Image: see text] Allylic cyclitols were investigated as covalent inhibitors of glycoside hydrolases by chemical, enzymatic, proteomic, and computational methods. This approach was inspired by the C(7) cyclitol natural product streptol glucoside, which features a potential carbohydrate leaving group in the 4-position (carbohydrate numbering). To test this hypothesis, carbocyclic inhibitors with leaving groups in the 4- and 6- positions were prepared. The results of enzyme kinetics analyses demonstrated that dinitrophenyl ethers covalently inhibit α-glucosidases of the GH13 family without reactivation. The labeled enzyme was studied by proteomics, and the active site residue Asp214 was identified as modified. Additionally, computational studies, including enzyme homology modeling and density functional theory (DFT) calculations, further delineate the electronic and structural requirements for activity. This study demonstrates that previously unexplored 4- and 6-positions can be exploited for successful inhibitor design. American Chemical Society 2023-03-20 /pmc/articles/PMC10131216/ /pubmed/37124289 http://dx.doi.org/10.1021/jacsau.3c00037 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Grayfer, Tatyana D. Yamani, Khalil Jung, Erik Chesnokov, Gleb A. Ferrara, Isabella Hsiao, Chien-Chi Georgiou, Antri Michel, Jeremy Bailly, Aurélien Sieber, Simon Eberl, Leo Gademann, Karl Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases |
title | Allylic Carbocyclic
Inhibitors Covalently Bind Glycoside
Hydrolases |
title_full | Allylic Carbocyclic
Inhibitors Covalently Bind Glycoside
Hydrolases |
title_fullStr | Allylic Carbocyclic
Inhibitors Covalently Bind Glycoside
Hydrolases |
title_full_unstemmed | Allylic Carbocyclic
Inhibitors Covalently Bind Glycoside
Hydrolases |
title_short | Allylic Carbocyclic
Inhibitors Covalently Bind Glycoside
Hydrolases |
title_sort | allylic carbocyclic
inhibitors covalently bind glycoside
hydrolases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131216/ https://www.ncbi.nlm.nih.gov/pubmed/37124289 http://dx.doi.org/10.1021/jacsau.3c00037 |
work_keys_str_mv | AT grayfertatyanad allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT yamanikhalil allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT jungerik allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT chesnokovgleba allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT ferraraisabella allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT hsiaochienchi allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT georgiouantri allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT micheljeremy allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT baillyaurelien allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT siebersimon allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT eberlleo allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases AT gademannkarl allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases |